Vaginal oestrogen improves prolapse surgery outcomes
In postmenopausal women undergoing primary prolapse surgery, perioperative treatment with vaginal oestrogen is associated with improvements in patient-reported outcomes and pelvic floor-related quality of life, as shown in a multicentre study.
